LC
Luc E. Coffeng
Also known as: LE Coffeng, Luc Edgar Coffeng
Erasmus MC, University of Washington, Erasmus University Rotterdam, University Medical Center Utrecht
Research areas: Immunology and Microbiology · Parasitology · Parasites and Host Interactions · Parasitic Diseases Research and Treatment · Mathematical and Theoretical Epidemiology and Ecology Models
0000-0002-4425-2264
Employment
-
Erasmus MC Assistant Professor2017 - Present
-
Erasmus MC Postdoctoral Researcher2014 - 2016
-
University of Washington Postgraduate Fellow2013 - 2014
-
Erasmus MC PhD student2008 - 2013
Education
-
Erasmus MC PhD? - 2013
-
Erasmus University Rotterdam MSc Health Sciences, specialisation in Epidemiology? - 2011
- ? - 2007
Projects & Funding
-
Resistance Evaluation and Surveillance Initiative for Schistosomiasis Treatment (RESIST) Wellcome2024 - 2027
Publications (123)
- Regulation of Schistosoma infections in snail populations: a modelling framework with inheritable resistance in snails Save
- Mapping spatial colleague connectivity patterns from individual-level registry data to inform regional pandemic interventions Save
- An intuitive sampling framework for setting-specific decision-making in soil-transmitted helminthiasis control programs Save
- Determinants of Quarantining Following a Contact Tracing App Notification in the Netherlands Save
- Target product profiles for new diagnostics to inform strongyloidiasis control programs Save
- Cost and budget impact of mass drug administration compared to expanded school-based targeted preventive chemotherapy for soil-transmitted helminth control in Zamboanga Peninsula, the Philippines Save
- Tobacco control policies and respiratory conditions among children presenting in primary care Save
- A Comparison of Markov and Mechanistic Models for Soil-Transmitted Helminth Prevalence Projections in the Context of Survey Design Save
- Accelerating Progress Towards the 2030 Neglected Tropical Diseases Targets: How Can Quantitative Modeling Support Programmatic Decisions? Save
- How Does Treatment Coverage and Proportion Never Treated Influence the Success of Schistosoma mansoni Elimination as a Public Health Problem by 2030? Save
- How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis? Save
- Improving the Cost-efficiency of Preventive Chemotherapy: Impact of New Diagnostics on Stopping Decisions for Control of Schistosomiasis Save
- Predictive Value of Microfilariae-Based Stop-MDA Thresholds After Triple Drug Therapy With IDA Against Lymphatic Filariasis in Treatment-Naive Indian Settings Save
- Cost-effectiveness of mass drug administration with ivermectin against strongyloidiasis: a modelling study Save
- Predicting the risk and speed of drug resistance emerging in soil-transmitted helminths during preventive chemotherapy Save
- Community-wide versus school-based targeted deworming for soil-transmitted helminth control in school-aged children in Vietnam Save
- Cost and cost-effectiveness analysis of mass drug administration compared to school-based targeted preventive chemotherapy for hookworm control in Dak Lak province, Vietnam Save
- How does treatment coverage and proportion never treated influence the success ofSchistosoma mansonielimination as a public health problem by 2030? Save
- A comparison of Markov and mechanistic models for STH prevalence projections in the context of survey design Save
- Improving the cost efficiency of preventive chemotherapy: impact of new diagnostics on stopping decisions for control of schistosomiasis Save